Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ALTANA Pharma U.S. Appoints Mark Salyer Senior Vice President of Sales and Marketing.


Business Editors

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Sept. 23, 2002

ALTANA Pharma U.S. today announced the appointment of Mark Salyer as Senior Vice President of Sales and Marketing.

Mr. Salyer will be responsible for new product launches, market development, and strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people.  for the company as it brings its promising pipeline of respiratory and gastrointestinal products to market.

"Mark's significant marketing experience and his broad knowledge of

the respiratory markets in particular will be a major asset to us as we develop our new products," said George Cole

For other people named George Cole, see George Cole (disambiguation).


George Edward Cole (born April 22, 1925 in Tooting, London, England) is an English actor.
, president, ALTANA Pharma U.S.

Mr. Salyer comes to ALTANA Pharma U.S. after a 17-year career at Glaxo SmithKline, where he most recently served as Global Commercial Strategy Vice President for the company's respiratory products based in London. In that role, he was responsible for global commercial strategy for current and pipeline products, making it Glaxo SmithKline's most promising product portfolio. Among his other positions at Glaxo SmithKline, he served as the director of marketing of the company's allergy, cardiovascular, asthma, chronic obstructive pulmonary disease chronic obstructive pulmonary disease
n. Abbr. COPD
A chronic lung disease, such as asthma or emphysema, in which breathing becomes slowed or forced.
 and migraine brands in the United States. Mark has a MBA MBA
abbr.
Master of Business Administration

Noun 1. MBA - a master's degree in business
Master in Business, Master in Business Administration
 from Duke University.

ALTANA Pharma

ALTANA Pharma, formerly Byk Gulden, is an international pharmaceutical company focused primarily on respiratory and gastrointestinal treatments. The company had pharmaceutical sales of $1.4 billion USD USD

In currencies, this is the abbreviation for the U.S. Dollar.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 in 2001. Its U.S.-based operations, headquartered in Florham Park, New Jersey Florham Park is a borough in Morris County, New Jersey, United States. As of the United States 2000 Census, the borough population was 8,857.

Florham Park was incorporated as a borough by an Act of the New Jersey Legislature on March 9, 1899, from portions of Chatham
, were established in 2002. A research-driven pharmaceutical company, ALTANA Pharma invests almost 20 percent of pharmaceutical sales into research. The company's rich history of drug development includes the discovery of the blockbuster proton pump inhibitor proton pump inhibitor
n.
A class of drugs that inhibit gastric acid secretion by interfering with the movement of hydrogen ions across cell membranes and are used mainly to treat peptic ulcers, gastroesophageal reflux disease, and esophagitis.
 pantoprazole, marketed in the United States by Wyeth-Ayerst as Protonix. Going forward, ALTANA Pharma's U.S. operations will market the products developed in its research facilities. ALTANA Pharma's parent company is ALTANA AG, based in Bad Homburg, Germany.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 23, 2002
Words:305
Previous Article:OSI Pharmaceuticals Receives Second FDA Fast-track Designation for Tarceva; Announces Amendments to Tarceva Development Plan.
Next Article:iShares to Offer New MSCI Emerging Markets Exchange Traded Fund.



Related Articles
NEWSMAKERS.
New agencies hold promise for the Garibaldi Group.
GBC BIOTECH PRESENTS NEW DATA ON EFFICACY OF SATRAPLATIN.
'RIVER' FIRST SHOW'.
METACORE PROVIDES MANUALLY CURATED HUMAN DATA BY PHD'S.
Altana Chemie signs agreement to acquire Eckart.
GROUP AIMS TO BRING BROADWAY TO THE VALLEY.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles